These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28562117)

  • 1. Omega-3 versus isoflavones in the control of vasomotor symptoms in postmenopausal women.
    Palacios S; Lilue M; Mejia A; Menendez C
    Gynecol Endocrinol; 2017 Dec; 33(12):951-957. PubMed ID: 28562117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study on the effects of S-equol compared to soy isoflavones on menopausal hot flash frequency.
    Jenks BH; Iwashita S; Nakagawa Y; Ragland K; Lee J; Carson WH; Ueno T; Uchiyama S
    J Womens Health (Larchmt); 2012 Jun; 21(6):674-82. PubMed ID: 22409590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial.
    Tice JA; Ettinger B; Ensrud K; Wallace R; Blackwell T; Cummings SR
    JAMA; 2003 Jul; 290(2):207-14. PubMed ID: 12851275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soy protein and isoflavone effects on vasomotor symptoms in peri- and postmenopausal women: the Soy Estrogen Alternative Study.
    Burke GL; Legault C; Anthony M; Bland DR; Morgan TM; Naughton MJ; Leggett K; Washburn SA; Vitolins MZ
    Menopause; 2003; 10(2):147-53. PubMed ID: 12627040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials.
    Taku K; Melby MK; Kronenberg F; Kurzer MS; Messina M
    Menopause; 2012 Jul; 19(7):776-90. PubMed ID: 22433977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of omega-3 supplements on vasomotor symptoms in menopausal women: A systematic review and meta-analysis.
    Mohammady M; Janani L; Jahanfar S; Mousavi MS
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():295-302. PubMed ID: 30056356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG; Drosman S; Helmond FA; Stathopoulos VM
    Menopause; 2006; 13(6):917-25. PubMed ID: 17006377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyunsaturated fatty acids (PUFAs) might reduce hot flushes: an indication from two controlled trials on soy isoflavones alone and with a PUFA supplement.
    Campagnoli C; Abbà C; Ambroggio S; Peris C; Perona M; Sanseverino P
    Maturitas; 2005 Jun; 51(2):127-34. PubMed ID: 15917152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of dose, frequency of administration, and equol production on efficacy of isoflavones for menopausal hot flashes: a pilot randomized trial.
    Crawford SL; Jackson EA; Churchill L; Lampe JW; Leung K; Ockene JK
    Menopause; 2013 Sep; 20(9):936-45. PubMed ID: 23511704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of isoflavones and amino acid therapies for hot flashes and co-occurring symptoms during the menopausal transition and early postmenopause: a systematic review.
    Thomas AJ; Ismail R; Taylor-Swanson L; Cray L; Schnall JG; Mitchell ES; Woods NF
    Maturitas; 2014 Aug; 78(4):263-76. PubMed ID: 24951101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial.
    Van Patten CL; Olivotto IA; Chambers GK; Gelmon KA; Hislop TG; Templeton E; Wattie A; Prior JC
    J Clin Oncol; 2002 Mar; 20(6):1449-55. PubMed ID: 11896091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical investigation of RAD1901, a novel estrogen receptor ligand, for the treatment of postmenopausal vasomotor symptoms: a phase 2 randomized, placebo-controlled, double-blind, dose-ranging, proof-of-concept trial.
    Hattersley G; Harris AG; Simon JA; Constantine GD
    Menopause; 2017 Jan; 24(1):92-99. PubMed ID: 27575546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy.
    Petri Nahas E; Nahás Neto J; De Luca L; Traiman P; Pontes A; Dalben I
    Maturitas; 2004 Aug; 48(4):372-80. PubMed ID: 15283929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
    Simon JA;
    Menopause; 2006; 13(2):222-31. PubMed ID: 16645536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study.
    Nahas EA; Nahas-Neto J; Orsatti FL; Carvalho EP; Oliveira ML; Dias R
    Maturitas; 2007 Nov; 58(3):249-58. PubMed ID: 17913408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equol Decreases Hot Flashes in Postmenopausal Women: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Daily JW; Ko BS; Ryuk J; Liu M; Zhang W; Park S
    J Med Food; 2019 Feb; 22(2):127-139. PubMed ID: 30592686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.
    Pinkerton JV; Constantine G; Hwang E; Cheng RF;
    Menopause; 2013 Jan; 20(1):28-37. PubMed ID: 23010882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial.
    Cohen LS; Joffe H; Guthrie KA; Ensrud KE; Freeman M; Carpenter JS; Learman LA; Newton KM; Reed SD; Manson JE; Sternfeld B; Caan B; Freeman EW; LaCroix AZ; Tinker LF; Booth-Laforce C; Larson JC; Anderson GL
    Menopause; 2014 Apr; 21(4):347-54. PubMed ID: 23982113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo.
    van de Weijer PH; Barentsen R
    Maturitas; 2002 Jul; 42(3):187-93. PubMed ID: 12161042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
    Gordon S; Walsh BW; Ciaccia AV; Siddhanti S; Rosen AS; Plouffe L
    Obstet Gynecol; 2004 Feb; 103(2):267-73. PubMed ID: 14754694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.